NextDocs Announces Partnership with Thomson Reuters
Philadelphia, PA- September 17, 2009
The integration between the NextDocs Document and Quality Management System and the Liquent InSight Platform allows the two systems to work from a common set of SharePoint-based documents. With SharePoint as a common repository, NextDocs system and theLiquent Regulatory Software are able to interact with one another; for example, organizations can access NextDocs documents housed in SharePoint and build an eCTD structure utilizing Thomson Reuters Liquent InSight Platform.
"Our Liquent InSight platform...provide[s] a single authoritative platform, which allows users to manage regulatory information through all stages of development, from early submissions to marketed registrations," said Rick Riegel, Vice President and General Manager, Services and Software Solutions at Thomson Reuters.
As part of the enhanced partnership, NextDocs will be offering Liquent SmartScribe® from Thomson Reuters. These templates enable users to create common technical documents quickly, efficiently and in a constant standard. The user friendly templates help to ensure all documents comply with format requirements.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Operational Strategies That Strengthened the NIMBLE Trial Design
September 16th 2025